NCT02206854View on ClinicalTrials.gov

Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

R-flurbiprofen

200 mg gelatine capsule once orally

Trial Locations (1)

60528

Johann Wolfgang Goethe University Hospital, Frankfurt

All Listed Sponsors

collaborator

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

OTHER

lead

Gerd Geisslinger

OTHER

NCT02206854 - Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter